NCT05367661View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CHK-336 in Healthy Volunteers

PHASE1TerminatedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

April 8, 2022

Primary Completion Date

April 19, 2023

Study Completion Date

April 19, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

CHK336

Tablet

DRUG

Placebo

Tablet

Trial Locations (1)

45227

Medpace Clinical Pharmacology Unit, Cincinnati

Sponsors
All Listed Sponsors
lead

Chinook Therapeutics, Inc.

INDUSTRY